ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

DoD Ovarian Cancer Research Program seeks proposals for FY05 funding.

October 1, 2004

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010

It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request

September 23, 1983

Pittsburgh Broadens Misconduct Inquiry

June 3, 1994

HHS News: Shalala To Form Genetic Testing Advisory Committee

August 14, 1998

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989